Improving Awareness and Outcomes Related to Venous Thromboembolism.
作者信息
Cushman Mary, Creager Mark A
机构信息
Cardiovascular Research Institute of Vermont, Department of Medicine, University of Vermont College of Medicine, Burlington2Thrombosis and Hemostasis Program, University of Vermont Medical Center, Burlington.
Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
出版信息
JAMA. 2015 Nov 10;314(18):1913-4. doi: 10.1001/jama.2015.15107.
Abstract
摘要
相似文献
1
Improving Awareness and Outcomes Related to Venous Thromboembolism.提高与静脉血栓栓塞相关的认知度及改善治疗结果
JAMA. 2015 Nov 10;314(18):1913-4. doi: 10.1001/jama.2015.15107.
2
Call to action to prevent venous thromboembolism.预防静脉血栓栓塞的行动呼吁。
J Vasc Surg. 2009 Jun;49(6):1620-3. doi: 10.1016/j.jvs.2009.01.058.
3
[Introduction. Venous thromboembolism in cancer patients].[引言。癌症患者的静脉血栓栓塞]
Med Clin (Barc). 2015 Jan;144 Suppl 1:1-2. doi: 10.1016/S0025-7753(15)30011-7.
4
5
Venous thromboembolism in hospitalised patients: a public health crisis?住院患者的静脉血栓栓塞症：一场公共卫生危机？
Br J Haematol. 2008 Jun;141(6):764-70. doi: 10.1111/j.1365-2141.2008.07141.x. Epub 2008 Apr 10.
6
Cancer patients and awareness of venous thromboembolism.癌症患者与静脉血栓栓塞症的认知。
Cancer Invest. 2010 Jan;28(1):44-5. doi: 10.3109/07357900902744544.
7
[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"].[匈牙利第四版抗血栓形成指南中“静脉血栓栓塞症的风险降低与治疗”里用于评估住院手术及非手术患者静脉血栓栓塞风险的问卷]
Orv Hetil. 2010 Aug 22;151(34):1365-74. doi: 10.1556/OH.2010.28944.
8
Effect of information on the perception of users and prospective users of combined oral contraceptives regarding the risk of venous thromboembolism.信息对复方口服避孕药使用者及潜在使用者关于静脉血栓栓塞风险认知的影响。
Gynecol Endocrinol. 2015 Jan;31(1):57-60. doi: 10.3109/09513590.2014.947568. Epub 2014 Aug 6.
9
Epidemiology of the contraceptive pill and venous thromboembolism.避孕药与静脉血栓栓塞症的流行病学。
Thromb Res. 2011 Feb;127 Suppl 3:S30-4. doi: 10.1016/S0049-3848(11)70009-3.
10
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry.静脉血栓栓塞和癌症患者的三个月死亡率和临床预测因素。RIETE 登记处的结果。
Thromb Res. 2013 Jan;131(1):24-30. doi: 10.1016/j.thromres.2012.10.007. Epub 2012 Nov 8.
引用本文的文献
1
New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants.新型基于三唑的人凝血因子XIIa强效抑制剂作为抗凝剂
ACS Omega. 2024 Feb 22;9(9):10694-10708. doi: 10.1021/acsomega.3c09335. eCollection 2024 Mar 5.
2
Measurement of the awareness of venous thromboembolism in the Saudi population.沙特人群中静脉血栓栓塞症知晓情况的测量。
Ann Thorac Med. 2023 Jan-Mar;18(1):15-22. doi: 10.4103/atm.atm_147_22. Epub 2023 Jan 25.
3
Epidemiology and prevention of venous thromboembolism.静脉血栓栓塞症的流行病学和预防。
Nat Rev Cardiol. 2023 Apr;20(4):248-262. doi: 10.1038/s41569-022-00787-6. Epub 2022 Oct 18.
4
Awareness level of deep vein thrombosis the general population living in the Western region of Saudi Arabia.沙特阿拉伯西部地区普通人群对深静脉血栓形成的知晓水平。
J Family Med Prim Care. 2022 May;11(5):1721-1727. doi: 10.4103/jfmpc.jfmpc_1175_21. Epub 2022 May 14.
5
Deep Venous Thrombosis in a Patient with a Moderate Pretest Probability and a Negative D-Dimer Test: A Review of the Diagnostic Algorithms.D-二聚体检测结果为阴性且临床预测试验概率为中度的患者发生深静脉血栓形成：诊断算法综述
J Blood Med. 2020 May 27;11:173-184. doi: 10.2147/JBM.S244773. eCollection 2020.
6
Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?肺栓塞患者的预后特征与体重指数：大小重要吗？
ERJ Open Res. 2020 Jan 10;6(1). doi: 10.1183/23120541.00163-2019. eCollection 2020 Jan.
7
Impact of drugs on venous thromboembolism risk in surgical patients.药物对手术患者静脉血栓栓塞风险的影响。
Eur J Clin Pharmacol. 2019 Jun;75(6):751-767. doi: 10.1007/s00228-019-02636-x. Epub 2019 Feb 5.
8
Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism.肥胖症患者大块和次大块肺栓塞的导管定向、超声辅助纤溶治疗。
J Thromb Thrombolysis. 2018 Feb;45(2):257-263. doi: 10.1007/s11239-018-1608-3.
9
Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.使用事件发生时间模型识别与风险因素的基因相互作用。
Int J Environ Res Public Health. 2017 Oct 15;14(10):1228. doi: 10.3390/ijerph14101228.
本文引用的文献
1
Deep vein thrombosis (DVT) and pulmonary embolism (PE): awareness and prophylaxis practices reported by patients with cancer.深静脉血栓形成（DVT）和肺栓塞（PE）：癌症患者报告的认知与预防措施
Cancer Invest. 2015;33(9):405-10. doi: 10.3109/07357907.2015.1048871. Epub 2015 Jul 16.
2
Global public awareness of venous thromboembolism.全球公众对静脉血栓栓塞症的认知。
J Thromb Haemost. 2015 Aug;13(8):1365-71. doi: 10.1111/jth.13031. Epub 2015 Jul 14.
3
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.《2015年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
4
Knowledge of the diagnostic algorithm for pulmonary embolism in primary care.基层医疗中肺栓塞诊断算法的知识。
Eur J Intern Med. 2015 Jan;26(1):18-22. doi: 10.1016/j.ejim.2014.11.005. Epub 2014 Dec 11.
5
The contribution of immobility risk factors to the incidence of venous thrombosis in an older population.久坐不动风险因素对老年人群静脉血栓栓塞症发生率的影响。
J Thromb Haemost. 2014;12(3):290-6. doi: 10.1111/jth.12480.
6
Effect of a public awareness campaign on the incidence of symptomatic objectively confirmed deep vein thrombosis: a controlled study.公众宣传活动对症状性客观证实的深静脉血栓形成发生率的影响：一项对照研究。
J Thromb Haemost. 2012 Nov;10(11):2287-90. doi: 10.1111/j.1538-7836.2012.04915.x.
7
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.抗凝药物治疗肺栓塞的对照试验。
Lancet. 1960 Jun 18;1(7138):1309-12. doi: 10.1016/s0140-6736(60)92299-6.
8
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.肥胖：静脉血栓形成风险以及与凝血因子水平和口服避孕药使用之间的相互作用。
Thromb Haemost. 2003 Mar;89(3):493-8.
9
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study.深静脉血栓形成和肺栓塞后生存的预测因素：一项基于人群的队列研究。
Arch Intern Med. 1999 Mar 8;159(5):445-53. doi: 10.1001/archinte.159.5.445.
Zotero 插件